Lu­ca Santarel­li's Vec­tivBio bags $100M-plus in new fund­ing from li­cens­ing pact, loan

Lu­ca Santarel­li’s rare dis­ease play­er Vec­tivBio, just three years out from be­ing found­ed by the Roche vet and just a year af­ter go­ing pub­lic on Nas­daq in a $127.5 mil­lion IPO, is look­ing to raise more cap­i­tal. And by the looks of it, the biotech is look­ing to solve that is­sue by en­ter­ing in­to two agree­ments to “strength­en” Vec­tivBio’s bal­ance sheet by well over $100 mil­lion.

Ac­cord­ing to the biotech, the agree­ments an­nounced this morn­ing will more than dou­ble the com­pa­ny’s work­ing cap­i­tal to $220 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER